It is a chemicals and materials private limited company based in Dombivli East, Maharashtra, India, established in 2019.
2019 | Dombivli East, Maharashtra, India | Struck OffRovina Pharma And Intermediate Chemicals Private Limited, a struck off private limited company, was established on 25 December 2019 in Dombivli East, Maharashtra, India. Engaging in industrial chemicals within the trade sector, it holds CIN: U51909MH2019PTC335003. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹60.00 K .
Its leadership includes Anil Shrikant Manavi (Director), Shrikant Wasudeo Narkhede (Director), Kota Praveen Rao (Director). Its latest AGM occurred on 17 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 903, Bldg No.16,Regency Estate, Kalyan-Shil Road,Dyaneshwar Nagar,, Dombivli East, Maharashtra, 421201.
U51909MH2019PTC335003
335003
25 December 2019
₹0.50 M
₹60.00 K
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Rovina Pharma And Intermediate Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anil Shrikant Manavi | Director | 25 Dec 2019 | Current |
| Shrikant Wasudeo Narkhede | Director | 25 Dec 2019 | Current |
| Kota Praveen Rao | Director | 25 Dec 2019 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rovina Pharma And Intermediate Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 39.32% decrease in profit. The company's net worth Soared by an impressive increase of 14.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Rovina Pharma And Intermediate Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rovina Pharma And Intermediate Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rovina Pharma And Intermediate Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rovina Pharma And Intermediate Chemicals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Rovina Pharma And Intermediate Chemicals Private Limited last Annual general meeting of members was held on 17 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Rovina Pharma And Intermediate Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Anil Shrikant Manavi was appointed as a Director was appointed as a Director on 25 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
Progress on Shrikant Wasudeo Narkhede was appointed as a Director was appointed as a Director on 25 Dec 2019 & has been associated with this company since 5 years 11 months . was documented.
The activity Kota Praveen Rao was appointed as a Director was appointed as a Director on 25 Dec 2019 & has been associated with this company since 5 years 11 months . was completed.
Progress on Rovina Pharma And Intermediate Chemicals Private Limited was registered on 25 Dec 2019 with Roc Mumbai & aged 5 years 11 months as per MCA records. was documented.
The CIN of Rovina Pharma And Intermediate Chemicals Private Limited is U51909MH2019PTC335003.
Rovina Pharma And Intermediate Chemicals Private Limited is headquartered at Flat No. 903, Bldg No.16,Regency Estate, Kalyan-Shil Road,Dyaneshwar Nagar,, Dombivli East, Maharashtra, 421201.
Rovina Pharma And Intermediate Chemicals Private Limited was incorporated on 25 December 2019.
The current directors of Rovina Pharma And Intermediate Chemicals Private Limited are
The primary industry of Rovina Pharma And Intermediate Chemicals Private Limited is Trade.
Rovina Pharma And Intermediate Chemicals Private Limited is unlisted.
The authorized capital of Rovina Pharma And Intermediate Chemicals Private Limited is ₹0.50 M, and the paid-up capital is ₹60.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX